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Purpose: Seventy-two-kilodalton ype IV collagenase (MMP-2), a potent collagenase and 
elastase, ispresent in inflammatory disease states and may be important in the pathogenesis 
of aortic aneurysms. Alteration in expression of MMP-2 or its inhibitor, the tissue 
inhibitor of metalloproteinases type two (TIMP-2), could increase xtraceUular matrix 
degradation and lead to aneurysm formation. The purpose of this study is (1) to measure 
relative tissue levels of MMP-2 and TIMP-2 mRNA in aneurysmal, occlusive, and normal 
human infrarenal aorta; (2) to test for expression by ctdtured aneurysmal nd normal 
vascular smooth muscle cells (VSMCs); and (3) to identify, in situ, the cells responsible 
for mRNA production within aneurysmal, ocelusive, and normal aortic wall. 
~lethods: Total RNA extracted from aneurysmal (n = 8), occlusive (n = 9), and normal 
(n = 7) tissue was subjected to Northern analysis. Signals for MMP-2 and TIMP-2 were 
normalized to «-tubulin. Mean values + SE were compared by use of analysis ofvariance. 
Aneurysmal nd normal VSMCs were cultured, passaged, and grown to confluence before 
R2qA extraction and Northern analysis. In situ hybridization with digoxigenin RNA 
probes localized cells responsible for MMP-2 and TIMP-2 mRNA production in 
histologic sections of aneurysmal (n = 7), occlusive (n = 4), and normal (n = 3) aorta. 
Results: Tissue MMP-2 mRNA levels were significantly greater in aneurysmal aorta 
(~[.032 + 0.164, n = 5) than in either occlusive (0.553 +- 0.027, n = 4, p < 0.02) or 
normal aorta (0.230 + 0.038, n = 3, p < 0.002). Differences in TIMP-2 mRNA levels 
were not significant (aneurysmal aorta 0.207-+ 0.042, n = 3; occlusive aorta 
0.413 + 0.164, n = 3; normal aorta 0.260 + 0.079, n = 4;p = 0.34), although num- 
bers were small. Cultured aneurysmal nd normal VSMCs constitutively expressed both 
MMP-2 and TIMP-2. In situ studies colocalized tissue MMP-2 and TIMP-2 expression 
to VSMCs and macrophages surrounding inflammation i aneurysmal dventita, but to 
atherosclerotic plaque in occlusive aorta. 
Conclusions: MMP-2 and TIMP-2 are expressed in aneurysmal, occlusive, and normal 
aorta. MMP-2 expression is significantly greater in aneurysmal than in either occlusive or 
normal aorta. Cultured aneurysmal VSMCs constitutively express both MMP-2 and 
TIMP-2. Differential patterns of expression seen in situ and elevated tissue MMP-2 
mRNA levels in aneurysmal versus occlusive aorta suggest that MMP-2 may be responsible 
flor localized plaque remodeling in occlusive disease and for diffuse adventitial collagen and 
elastin destruction i  aneurysms. (J VAsc SURG 1995;22:295-305.) 
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The aneurysmal orta is characterized by disrup- 
tion of its orderly pattern of medial and adventitial 
collagen and elastin. 1-s Medial elastin is typically 
fragmented, and previous investigators have shown 
that adventitial elastin destruction occurs early in 
aneurysm formation. «~ Aortic collagen fibers pre- 
dominate in the adventitia, and electron micrographs 
of aortic aneurysms display ultrastructural patterns 
suggestive of ongoing collagen degradation and 
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disordered replacement. 6 Dobrin et al. 7 have studied 
the relative contribution of elastin and collagen to 
aortic wall strength in vitro. They postulate that 
elastin destruction is responsible for early aortic 
expansion and loss of recoil but that collagen 
destruction is necessary for continued expansion 
leading to eventual rupture. 7,8 Subsequent authors 
have also argued that both collagen and elastin 
destruction are necessary for aneurysm formation, 
pointing out that the tensile strength of collagen is 
four orders ofmagnitude greater than that ofelastin. 9 
The aneurysm wall is also characterized by 
inflammatory infiltrates. Koch et al.10 have noted 
increased numbers of inflammatory infiltrates in 
aneurysms as compared with occlusive and normal 
aorta. Subsequent investigators in our laboratory and 
others have identified elevated levels of several 
associated cytokines, including interleukin-l[3, 
interleukin-8, and tumor necrosis factor-a, n13 One 
theory of aneurysm formation contends that these 
inflammatory cytokines timulate chronic overpro- 
duction of enzymes responsible for collagen and 
elastin destruction. 
Metalloproteinases (MMPs) are the major class of 
proteins responsible for matrix destruction. Busutril 
et al. ~4 first recognized that aneurysmal cxtracts had 
significant collagenolytic and elastolytic activities 
over 13 years ago. Subsequent investigators have 
identified human collagenase (MMP-1), stromelysin 
(MMP-3), and 92 kd type IV collagenase (MMP-9) 
within diseased aorta and attributed observed in- 
creases in aneurysmal degratory activity to these 
enzymes? 547 Workers in our laboratory and others 
have demonstrated differences in protein levels 
(MMP-9 la and MMP-116) and expression (MMP- 
9 ~5) of metalloproteinases b tween aneurysmal nd 
normal aorta; however, no significant differences in
levels of mRNA expression between occlusive and 
aneurysmal orta have been identified. 
MMP-2 is a potentially important enzyme in the 
pathogenesis of aortic aneurysms. Of all the metal- 
loproteinases, only MMP-2 and MMP-9 can degrade 
a variety of substrates, including both collagen (types 
IV, V, and X and gelatin) and elastin. ~9 Unlike 
MMP-9, which is produced exclusively by the 
macrophage/monocyte cell line, investigators have 
noted MMP-2 production by macrophages, tibro- 
blasts, and smooth muscle cells. 19-21 Furthermore, 
MMP-2 is unique in that it is inhibited by the tissue 
inhibitor of metalloproteinases type 2 (T IMP-2) .  22 
Substrate specificity for both coUagen and elastin, a 
unique system of inhibition, and potential for pro- 
duction by three of the major cell types comprising 
the aortic wall suggest that MMP-2 could be respon- 
sible for many of the structural changes that charac- 
terize aneurysmal disease. 
This study proposes to measure relative levels of 
MMP-2 and TIMP-2 mRNA expression i aneurys- 
mal, occlusive, and normal aortic tissue specimens, 
&termine the presence or absence of expression by 
vascular smooth muscle cells cultured from aneurys- 
mal and normal aorta, locate the ceU type responsible 
for mRNA production i  situ, and thereby provide a 
clearer understanding of the role of MMP-2 in 
aneurysmal nd occlusive aortic disease. 
MATERIAL AND METHODS 
Infrarenal aortic specimens were obtained from 
patients providing informed consent before either 
abdominal aortic aneurysm resection (16 patients, 
average age 66 years, male/female ratio 14:2) or 
aortobifemoral bypass for occlusive disease (13 
patients, average age 60 years, male/female ratio 
10:3) in accordance with the Institutional Review 
Board and Research Committee of Northwestern 
University/McGaw Medical Center. Specimens of 
normal aorta (11 patients, average age 60 years, 
malle/female ratio 7:4) were obtained at the time of 
organ procurement or autopsy. All specimens were 
obtained approximately 3 to ö cm below the renal 
arteries. Specimens were placed immediately in either 
liquid nitrogen (tissue mRNA extraction), Streck 
tissue fixative (in situ hybridization) (Streck Labora- 
tory, Omaha, Neb.) or Dulbecco's modified Eagle 
media (cell culmre). 
RNA extraction and Northern transfer hy- 
bridization. Aortic tissue from patients undergoing 
aneurysm resection (n = 8) or aortic bypass for 
ocdusive disease (n = 9) and from normal donors 
(n = 7) was snap frozen in liquid nitrogen and stored 
at - 80 ° C until use. RNA extraction and Northern 
transfer took place as previously described, 23produc- 
ing two membranes for hybridization. Probes were 
synthesized from previously characterized cDNA of 
MMP-2, 2° TIMP-2, 24 or cx-tubulin, 2s random prim- 
ers, and phosphorus 32-adenosine triphosphate with 
a Prime-It II kit (Stratagene, La Jolla, Calif.). Specific 
activity of each probe was determined with a 
scintillation counter and was greater than 1 x 106 
cpm/ng. Hybridization proceeded at68 ° C according 
to the protocol accompanying the Quik Hyb (Strat- 
agene) hybridization solution. Probes for «-tubulin 
and MMP-2 or TIMP-2 were hybridized to the same 
membrane. Autoradiographs were made by exposing 
the membranes to x-ray film (Hyperrad-TM, Amer- 
sham, Arlington Heights, Ill.) at -80  ° C for 24 
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Fig. 1. Northern blot analysis ofmRNA from infrarenal aortic tissue ofpatients with aortoiliac 
occlusive disease (AOD), patients with aneurysms (AAA), and control subjects (NA). 
Radiolabeled cDNA probes for 72 kD type IV collagenase (MMP-2) hybridized to rnessages 
of lengths 3.1 kb. Probes for human ci-mbulin hybridized to 1.6 kb mRNA in all lanes, 
indicating adequate amounts of total RNA were loaded in each welk Human foreskin fibroblasts 
(H.S.-68, ATCC) served as a positive control during the hybridization (+). 
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Fig. 2. MMP-2 messenger RNA in abdominal ortic aneurysms (AAA), occlusive aortoiliac 
tissue (AOD), and normal infrarenal aorta (NA). All signals were normalized to c~-tubulin to
control for loading differences intotal RNA and were expressed as mean -+ SD. MMP-2 mRNA 
levels were increased significantly in aneurysmal tissue when compared with occlusive 
(p < 0.02) and normal aorta (p < 0.002). No significant differences between MMP-2 occlusive 
and normal tissue mRNA levels were identified. 
hours. Quantification of mRNA levels proceeded as 
described previously 23with laser densitometric as- 
sessment of autoradiographs (TIMP-2 densitometric 
measurements reflected the sum ofvalues for the two 
isoforms). MMP-2 and TIMP-2 mRNA signals were 
normalized to the signal for ~-tubulin, a constim- 
tively expressed protein in mammalian cells, to 
control for differences in intensity caused by variable 
amounts of RNA in each lane. Analysis of variance 
(ANOVA) and Fischer's protected least square of 
differences were used for statistical analysis. Differ- 
ences were considered significant at 95% confidence 
(p < 0.05), reported as mean plus or minus standard 
error of the mean, and displayed graphically with 
standard eviation error bars. 
Cell culture. Tissue samples of aortic aneurysm 
and normal aorta were immediately processed after 
transport in sterile Dulbecco's modified Eagle me- 
dium. The tissue was minced and placed in M-199 
media with i5% fetal bovine serum (Sigma Chemical 
Co., St. Louis, Mo.), 0.05 mg/ml endothelial cell 
growth supplement (Sigma Chemical Co.), 120 
units/ml penicillin G, 120 txg/ml streptomycin, and 
2.5 ixg/ml amphotericin B (Fungizone). Cells were 
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Fig. 3. Northern blot analysis of mRNA from inffarenal 
aortic tissue ofpatients with aneurysms (AAA) oraortoiliac 
occlusive disease (AOD) and control subjects (/gA). 
Radio-labeled cDNA probes for TIMP-2 hybridized to 
mRNA oftwo isoforms with lengths of 3.5 kb and 1.0 kb. 
Probes for human «-mbulin hybridized to 1.6 kb mRNA 
in all lanes, indicating that adequate amounts of t tal RNA 
were loaded in each weil. 
grown to confluence in 5% CO2, passaged with 
0.25% trypsin, and harvested after passage three. Cell 
type was confirmed by staining with monoclo- 
nal anti-ci-smooth muscle actin antibody (Sigma 
A-2547) counterstained with rhodamine-labeled 
goat anti-mouse immunoglobin (Cappel Organon 
Teknika, Durham, N.C.). CeH medium was changed 
to serum-free ITS + Premix (Collaborative Biomedi- 
cal, Bedford, Mass.) in M-199 (1 : 100, vol/vol) for 
48 hours before mRNA extraction. After RNA 
extraction and Northern transfer, membranes were 
hybridized with cDNA probes for MMP-22° and 
TIMP-2. 24 
In situ hybridization. Probes for MMP-22° and 
TIMP-224 were provided by Dr. Gregory Goldberg 
(Washington University, St. Louis, Mo.) and Dr. 
Williarn Stetler-Stevenson (National Cancer Insti- 
tute, Bethesda, Md.). Bluescript pKS plasmids con- 
taining the probes were lincarized with restriction 
enzymes to create templates for unidirectional syn- 
thesis of digoxigenin-labeled RNA probes with 
specific promoters in accord with the methods from 
a Genius IV Riboprobe Synthcsis Kit (Boeh- 
ringer Manheim, Indianapolis, Ind.) (MMP-2 AS = 
T7/EcoRI, MMP-2 S XBA-1/T3, TIMP-2 AS = 
T7/EcoRI, TIMP-2 S = T3/SAC-I[Klenow en- 
zyme added to digest 3' sticky end]). Transcripts 
were checked on 1% agarosc gel and concen- 
trations determined by serial dilution color reaction 
against known concentrations of control-labeled 
RNA. 
Paraffinized 4 ~m sections of aortic tissuc (seven 
aneurysmal, four occlusive, and three normal) fixed in 
Streck Tissue Fixative were placed on Vectabond 
(Vector Labs, Burlingam, Calif.) coated Fischer 
Superfrost (Fisher Scientific, Pittsburgh, Pa.) slides. 
Slides were deparaffinized and hydrated through 
descending ethanol concentrations into diethylpyro- 
carbonate (DEPC)-treated water. Pretreatment fol- 
lowed a modification of the methods of Hillian et 
al. 26 and included incubation with 7.5 Ixg/ml pro- 
teinase K, 4% paraformaldehyde fLxation, and acety- 
lation in 0.25% acetic anhydride. Slides were rinsed 
with 2 x SSC, dehydrated through ascending etha- 
nol concentrations, and prehybridized for two hours 
with 50% formamide in 2 x SSC at 47 ° C. A 
modification of the hybridization technique de- 
scribed by Young 27 was followed: Five microliters 
(500 ng) of newly synthesized probe were added to 
3 Ixl of DEPC-treated water and 4 Ixl of ribonucleic 
acid mix (sheared salmon sperm DNA 2.5 mg/tal, 
yeast total RNA 6.3 mg/ml, yeast RNA 6.2 mg/tal, 
and DEPC H20 187 ~xl/ml), heated to 65 ° C for 5 
minutes and cooled on ice for 1 minute. Eighty-eight 
microliters of hybridization buffer (1 mol/L Tris- 
HCL, pH = 7.4, 24 ixl/ml; 100 mmol/L ethylene- 
diamine tetraacetic acid, pH = 8, 12 txl/ml; 3 mol/L 
NaC1 125 Ixl/ml; formamide 100%, 595 Ixl/ml; 
dextran sulfate 10 mg/ml; Denhardt's solution 50 x, 
24 ixl/ml; DEPC H20 , 25 ~l/ml) were added at 
room temperature. The resulting 100 ~1 of hybrid- 
ization mix were added toeach slide before they were 
secured with a coverslip and placed in a humidified 
chamber at 47 ° C for 14 to 16 hours. Slides were 
washed four times in 4 x SSC, treated with 300 Ixl 
RNAase A (40 txg/ml) at 37 ° C for 30 minutes to 
remove unbound probe, washed for 10 minutes each 
in 2 x SSC, 1 x SSC, 0.5 x SSC and 0.1 x SSC at 
room temperature, and washed twice in 0.1 x SSC at 
58 ° C for 30 minutes. Slides were then dehydrated 
quickly through ascending concentrations ofethanol 
and washed in digoxigenin buffer 1 (0.1 mol/L 
Tris-HCl; 0.15 mol/L NaC1, pH = 7.5). Slides were 
blocked in a solution containing buffer 1, 3% Vector 
goat serum (Vector Labs, Burlingame, Calif.) and 
0.3% Triton X-100 for 30 minutes before incubation 
with 100 txl ofdiluted antidigoxigenin a tibody/alka- 
line phosphatase conjugate (antibody conjugate 
1:3000 in buffer 1 with 3% goat serum and 0.3% 
Triton X-100) for 5 hours. Subsequent washes 
included buffer 1 for 10 minutes and buffer 3 
(Tris-HC1, 100 mmol/L; NaC1 100 mmol/L; MgC12 
50 mmol/L; pH = 9.5) for 2 minutes. Three hun- 
dred microliters of color substrate solution (45 txl 
Nitroblue Tetrazolium salt, 35 ~xl X-phosphate and 
2.4 mg levamisole in 10 ml buffer 3) were added to 
each slide before placement in a humid dark chamber 
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Fig. 4. TIMP-2 messenger RNA in abdominal aortic aneurysms (AAA), occlusive aortoiliac 
tissue (AOD), and normal infrarenal aorta (2gA). All signals were normalized to «-mbulin to 
control for loading differences in total RNA and were expressed as mean _+ standard eviation. 
No significant differences in TIMP-2 tissue mRNA levels between tissue types were identified. 
MMP-2 mRNA in VSMC's 
3.1 k.b. 
NA AAA 
TIMP-2 mRNA in VSMC's 
// 
RA AAA 
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Fig. 5. Northern blot analysis ofmRNA from culmred normal and aneurysm vascular smooth 
muscle cells. Radio-labeled cDNA probes for MMP-2 bound to mRNA at 3.1 kb on blots of 
both aneurysm and normal VSMCs. Likewise, probes bound to two expected isoforms (3.5 kb 
and 1.0 kb) of TIMP-2 mRNA on Northern blots of aneurysm and normal VSMCs. 
for 16 hours. Rinsing slides in buffer 4 (Tris-HC1 10 
mM/L; ethylenediamine tetraacetic acid 1 mmol/L; 
pH = 8) and washing in 500 ml 0.1 × SSC for 30 
minutes completed the reaction. Slides were coun- 
terstained with hematoxylin and secured with a 
coverslip with use of Crystalmount (Biomedia, Fos- 
ter City, Calif.) aqueous-based mounting medium. 
Mternating serial sections of aorta taken at 
operation were stalned simultaneously with sense and 
antisense probes. All sections were examined under 
light microscopy, in a blinded fashion by a single 
pathologist, o determine positivity and the location 
and cell type producing the mRNA of interest. 
Immunohistochemical staining with antibody to 
~-smooth muscle actin (Sigma Chemical Co.) and 
macrophage/histiocyte antigen Mac 387 (Dakopatts, 
Glostrup, Denmark) on unstained alternating sec- 
tions aided cell type identification. More than 10 
sections of  each specimen were stained with each of 
the four RNA probes m limit the possibility of 
intrasample variability. 
KESULTS 
Tissue mKNA. Signal for MMP-2 mKNA was 
present in all aneurysmal (n = 5), occlusive (n = 4), 
and normal aortic (n = 3) samples tested (Fig. 1). 
Mean MMP-2/~-tubulin mRNA signals were almost 
two times higher in aneurysms compared with 
occlusive aorta and five times higher than ormal 
aortic tissue. ANOVA demonstrated that the differ- 
ences between groups were significant (p < 0.005). 
Fischer's protected least square difference testing 
showed that differences between aneurysmal and 
occlnsive aortas (1.032 -+ 0.164vs. 0.553 + 0.027, 
p < 0.02) and aneurysmal and normal aortas 
(1.032 + 0.164 rs. 0.230 + 0.038, p < 0.002) 
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Fig. 6. Digoxigenin-labeled RNA probes binding to MMP-2 mRNA within aneurysmal tissue 
sections. Low-power view (A, original magnification x 16) demonstrates antisense probes 
binding to macrophages within adventitial inflammatory infiltrate. No b nding of sense probes 
(negative control) is seen on adjacent section (B, original magnification x 16). Higher power 
views show cytoplasmic staining within macrophages (C, original magnification x 60) and 
adjacent vascular smooth muscle cells (D,original magnification x 40). 
were both significant. There was no significant 
difference in MMP-2/«-tubulin mRNA signal be- 
tween occlusive and normal aortas (20 = 0.32) (Fig. 
2). Signal for TIMP-2 mRNA was present in all 
aneurysmal (n = 3), all occlusive (n = 3), and all 
normal (n = 4) samples tested (Fig. 3). Differences 
in TIMP-1/«-mbulin mRNA ratios between fissue 
types did not reach statistical significance (p = 
0.34) (aneurysmal, 0.207 _ 0.042; occlusive, 
0.413 - 0.164; normal, 0.260 -+ 0.079) (Fig. 4). 
Cultured vascular smooth muscle ell mKNA. 
Normal and aneurysmal aortic cultured vascular 
smooth muscle ceUs constitufively expressed MMP-2 
and TIMP-2 mRNA (Fig. 5). 
In situ hybridization. In situ hybridization 
demonstrated MMP-2 and TIMP-2 in all four 
atherosclerotic and seven aneurysmal ortic tissue 
specimens teste& No binding of either probe was 
detected infour normal ortic specimens. No binding 
of sense probes was seen in any specimen. 
In aneurysm tissue the probe for MMP-2 bound 
diffusely m mRNA in adventitial macrophages and 
smooth muscle ceUs. Macrophages expressing 
MMP-2 were located within inflammatory infiltrates 
and in areas surrounding vasa vasonun. Smooth 
muscle cells expressing MMP-2 stained iffusely in 
the adventitia nd orten colocalized to areas with 
posifively staining macrophages (Fig. 6). In occlusive 
fissue, probes for MMP-2 bound primarily to mac- 
rophages within the atherosclerofic plaque, although 
occasional binding to adventitial smooth muscle cells 
was seen (Fig. 7). Macrophage and smooth muscle 
cell types were confirmed by «-actin and Mac 387 
staining of adjacent secfions. 
Probes for TIMP-2 also botmd to mRNA of 
advenfifial smooth muscle cells and macrophages. In 
aneurysms TIMP-2 probes bound to similar areas as 
those for MMP-2, including adventifial smooth 
muscle cells, macrophages surrounding vasa va- 
sorum, and macrophages within inflammatory infil- 
trates (Fig. 8). TIMP-2 probes in occlusive specimens 
bound to macrophages within the atherosclerofic 
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Fig. 7. Digoxigenin-labeled RNA probes binding toMMP-2 mRNA within occlusive tissue 
sections. Low-power view (A, original magnification x 16) demonstrates antisense probes 
binding to macrophages within luminal atherosderotic plaque and absence of binding within 
aortic wall. Higher power views (B, original magnification x 40 and C, original magnification 
x 80) demonstrate cytoplasmic staining within macrophages adjacent to are s of neovascular- 
ization within atherosclerotic plaque. MAC 387 immunohistochemical staining of adjacent 
tissue section (D, original magnification x 40) confirmed macrophages cell type. 
plaque and, occasionally, to adventitial vascular 
smooth muscle cells (Fig. 9). Cell type was confirmed 
by positive staining results of similar areas on 
alternating sections with c~-smooth muscle actin and 
Mac 387. 
DISCUSSION 
In the 15 years since Busuttil et a1.14 first identified 
collagenolytic activity in aortic aneurysms, several 
groups have studied the potential role ofmetallopro- 
teinases in aneurysmal disease. Recent advances in 
molecular and biochemical techniques have ac- 
counted for a number of publications and an 
accompanying increase in understanding of the 
relationship between metalloproteinases and aortic 
disease. 1517,2s Studies of MMP-2 and TIMP-2 ex- 
pression should add to this understanding. 
Our tissue mRNA smdies demonstrate that 
MMP-2 expression is significantly greater in aneu- 
rysms than in either occlusive or normal aorta. 
Previous smdies have identified elevated protein 
levels and mRNA expression ofmetalloproteinases in 
aneurysms as compared with normal aorta, ls,lóJs but 
out finding of elevated MMP-2 expression in aneu- 
rysmal aortas as compared with occlusive aortas 
represents the first identified difference in metallo- 
proteinase xpression between the t-wo diseases. 
Potential explanations for differences in MMP-2 
expression i clude increased numbers ofcells express- 
ing the enzyme, increased levels of expression by 
individual cells or increased half-life of MMP-2 
mRNA within aneurysmal tissue. Differences in 
TIMP-2 expression between tissue types did not 
reach statistical significance, although, interestingly, 
mean levels were lowest in aneurysms. Comparison 
of absolute TIMP-2 and MMP-2 mRNA levels 
within a given tissue type (i.e., aneurysm MMP-2 vs 
TIMP-2), although conceptually important, is ex- 
tremely difficult with Northern technique because of 
inherent differences in probe specific activity and 
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Fig. 8. Digoxigenin-labeledRNAprobesbindingtoTIMP-2mRNAwithinaneurysmaltissue 
sections. Low-power view (A, original magnification x 16) demonstrates diffuse staining within 
adventitial vascular smooth muscle cells adjacent to inflammatory infiltrates. Higher power view 
of same area (B, original magnification x 80) shows vascular smooth muscle cells staining for 
TIMP-2 mKNA. High-power view (C, original magnification x 80) shows macrophages within 
an aneurysm adventitial inflammatory infiltrate also st ining positively forTIMP-2 mRNA. 
Alpha-actin immunohistochemical staining ofadjacent section (D, original magnification x 16) 
confirmed smooth muscle cell type (note similar pattern of staining outlined byarrows). 
bincling efficiency. Future studies that use a competi- 
tive polymerase chain reaction would allow for such 
comparisons and thereby provide further insight into 
the significance of isolated elevations of metallopro- 
teinase xpression within aneurysm tissue. Nonethe- 
less, our finding of elevated MMP-2 expression in 
aneurysms, as compared with both occlusive and 
normal aorta, suggests that this enzyme has a role in 
the characteristic structural changes that accompany 
aneurysm formation. 
MMP-2 and TIMP-2 were constitutively ex- 
pressed by vascular smooth muscle cells cultured 
from aneurysmal nd normal aorta. Demonstration 
of constitutive mRNA expression of these enzymes 
by cultured aortic vascular smooth muscle cells is in 
agreement with the work of previous authors who 
have shown constitutive MMP-2 protein production 
by aortic smooth muscle cells in culture, 29 MMP-2 
mRNA expression by cultured bronchial cpithe- 
lium, 2° and TIMP-2 mRNA expression by culmred 
fibroblasts. 21Although ceU culture results suggest 
that smooth muscle ceU expression of these enzymes 
is possible, confirmatory in situ hybridization studies 
were necessary toshow that expression occurs in vivo. 
In situ studies howed colocalization of MMP-2 
and TIMP-2 expression i  aneurysmal nd occlusive 
aortas by both macrophages and vascular smooth 
muscle cells. However, patterns of expression were 
distinct for the two disease stares. 
In aneurysms, MMP-2 and TIMP-2 were primar- 
ily expressed by adventitial cells. Adventitial vascular 
smooth muscle cells adjacent to inflammatory infil- 
trates tained iffusely. Probes also bound to macro- 
phages within inflammatory infiltrates and in areas 
surrotmding adventitial vasa vasorum. In occlusive 
tissue, MMP-2 and TIMP-2 were primarily expressed 
by cells within the atherosclerouc plaque, and only 
occasional adventitial expression was noted. Within 
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Fig. 9. Digoxigenin-labeled antisense RNA probes binding to TIMP-2 mRNA within 
occlusive aorta. Low-power view (A, original magnification × 40) demonstrates cytoplasmic 
staining with a localized cluster of adventitial smooth muscle cells. Cell type was confirmed by 
alpha-actin mmunohistochemical staining of adjacent section (B,original magnification × 80). 
Sense probes (negative control) did not bind to adjacent sections (C, original magnification 
× 40). Higher power view (D, original magnification × 80) demonstrates cytoplasmic staining 
of vascular smooth muscle cells. 
the occhasive plaque, probes bound to macrophages 
associated with inflammation and surrounding areas 
of neovascularization. Occlusive adventitial expres- 
sion was limited to occasional clusters of vascular 
smooth muscle cells. In sim probes did not bind in 
normal fissue sections, despite detection of MMP-2 
and TIMP-2 on Northern blots. Apparently local 
tissue concentrations were below the sensitivity of the 
in sim technique, because probes hybridize ffectively 
only when concentrafions of mRNA in localized 
subsets of cells are high and are less effëctive with 
large numbers of weakly expressive cells. 3° Alterna- 
JOURNAL OF VASCULAR SURGERY 
304 Mc~lillan et al. September 1995 
tively, the absence of binding in normal tissue may 
have been related to differing tissue response to 
proteinase K digestion or subtle differences in tissue 
preparation resulting from organ harvest. 
Our in situ results confirm previous tudies that 
suggest that metalloproteinase ynthesis occurs 
within the diseased aortic wall and does not merely 
reflect protein transport by infiltrating inflammatory 
cells. 1~ Likewise the colocalization of MMP-2 and 
TIMP-2 expression mirrors previous observations 
from in vitro studies that suggest that he enzymes are 
often expressed simultaneously. 22 The apparent asso- 
ciation of expression with inflammation in both 
aneurysmal nd occlusive specimens uggests that 
cytokine stimulation may induce expression within 
macrophages and endogenous vascular smooth 
muscle cells. Expression ofMMP-2 by macrophages 
surrounding neovascularization within occlusive 
plaques and aneurysm adventitia suggests that the 
enzyme may degrade extracellular matrix during 
neovascularizauon. The differential pattern ofexpres- 
sion in the two disease states uggests that MMP-2 is 
involved in plaque remodeling in occlusive disease, 
whereas in aneurysms it is responsible for diffuse 
adventitial matrix degradation associated with ongo- 
ing aortic wall expansion. 
The patterns of expression identified in in situ 
studies also offer a potential explanation for differ- 
ences in tissue MMP-2 mRNA levels between 
aneurysmal and occlusive aorta. Localization of 
expression toareas in and surrounding inflammation, 
combined with the observation by Koch et al.10 that 
aneurysms contain greater numbers of inflammatory 
cells than do occlusive aortas, suggests that increases 
in inflammation result in increased expression of 
MMP-2 within aneurysms. However, in contrast to 
in situ results demonstrating colocalization of 
TIMP-2 and MMP-2, tissue extraction experiments 
did not demonstrate differences in TIMP-2 levels. 
This may be explained by the fact that cytokines are 
known to induce differential patterns of expression of 
MMPs and TIMPs in vitro, 2~ so that MMP-2 
expression might be increased and TIMP-2 expres- 
sion decreased by a particular cytokine. It is possible 
that MMP-2 and TIMP-2 display different patterns 
of expression despite similar amounts of inflamma- 
tion within a given tissue section. 
An important question relating to this study and 
many others concerns the role of translational nd 
posttranslational modification in eventual protein 
levels. The efficiency of translation of expressed 
mRNA for MMP-2 and TIMP-2 within the aortic 
wall is unknown. However, work by previous inves- 
tigators upports our molecular data by identifying 
similar patterns of protein expression for MMP-2. 
Substrate gel enzymography with aortic wall extracts 
identified bands of activity with molecular weights 
corresponding to activated and bound isoforms of 
MMP-2 in aneurysms but not occlusive aortas. 17 
Further studies with tissue zymography localized 
elastolytic and collagenolytic a tivity to the adventitia 
of aneurysms and the luminal plaque of occlusive 
aorta. 17 Although many of the more subtle aspects 
concerning protein levels and translational efficiency 
remain unknown, the identification of elevated, 
localized MMP-2 mRNA expression within the 
aortic wall combined with similar patterns ofprotein 
expression suggests that the enzyme does have a role 
in aneurysmal disease. 
We conclude that MMP-2 expression is signifi- 
cantly greater in aneurysms than in either occlusive or 
normal aorta. Furthermore, cultured aneurysm and 
normal vascular smooth muscle cells constitutively 
express both MMP-2 and TIMP-2. MMP-2 and 
TIMP-2 are expressed by macrophages and vascular 
smooth muscle cells within diseased aorta, although 
the patterns of expression differ in aneurysms and 
occlusives. MMP-2 and TIMP-2 expression i occlu- 
sive disease is localized primarily to the atheroscle- 
rotic plaque, whereas it is localized to the adventitia 
of aneurysms. Elevated levels of MMP-2 expression 
localized to vascular smooth muscle cells and mac- 
rophages in the adventitia of aorfic aneurysms 
suggest hat this enzyme may participate in the 
adventitial collagen and elastin destruction that 
characterize this disease. 
We thank Maria Cipollone and Vera P. Shively for their 
insight and technical support in preparation of this 
manuscript. 
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